The IL28B locus attracted the attention of HCV researchers after a series of genome-wide
association studies independently identified a strong association between common IL28B …

Liver cancer, which is most often associated with virus infection, is prevalent worldwide, and
its underlying etiology and genomic structure are heterogeneous. Here we provide a whole …

Objective This trial compared the efficacy and safety of transarterial chemoembolisation
(TACE) plus sorafenib with TACE alone using a newly established TACE-specific endpoint …

AIM: To assess the clinical features and prognosis of 151 patients with extrahepatic
metastases from primary hepatocellular carcinoma (HCC), and describe the treatment …

Background & Aims Biliary tract cancers (BTCs) are clinically and pathologically
heterogeneous and respond poorly to treatment. Genomic profiling can offer a clearer …

Background Hepatic arterial infusion chemotherapy plus sorafenib in phase 2 trials has
shown favourable tumour control and a manageable safety profile in patients with advanced …

Intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma show
varying degrees of biliary epithelial differentiation, which can be defined as liver cancer …

Background & Aims Chronic hepatitis C virus (HCV) infection is an important risk factor for
hepatocellular carcinoma (HCC). Despite effective antiviral therapies, the risk for HCC is …

Prediction of hepatocellular carcinoma (HCC) risk is an urgent unmet need in patients with
nonalcoholic fatty liver disease (NAFLD). In cohorts of 409 patients with NAFLD from …

Telomere shortening in human liver with aging and chronic inflammation was examined by
hybridization protection assay using telomere and Alu probes. The reduction rate of …